Jackson Acquisition Company II (JACS)
Blank-check company seeking a healthcare services or technology business combination.
Something off on this page? Send us feedback.
Seeks to merge with a business—primarily in healthcare services or healthcare technology—and take the combined company public. Before a deal, it earns no operating revenue and is structured around a trust-funded search, shareholder redemptions, and NYSE combination rules.
Operates as a blank-check company seeking one business combination, with a stated emphasis on healthcare services and healthcare technology. It has no acquired operating business, products, customers, or commercial revenue; its work is to identify targets, conduct business, financial, legal, and operational due diligence, and arrange a transaction through trust assets, equity, debt, or a combination.
Sponsored by RJ Healthcare SPAC II, LLC, an affiliate of Jackson Healthcare and Jackson Investment Group, it relies on leadership networks in healthcare operations and finance for sourcing and evaluation. The search may span any industry or geography, while its practical aim is a private healthcare-services company that would benefit from a public listing and public capital. A combination must meet NYSE target-value rules and provide a controlling interest.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $358.3K · Total debt $198.0K · Total assets $247.3M · Shareholders' equity $246.7M
- Revenue
- $0
- Operating income
- −$184.6K
- Net income
- $2.0M
No dividends on record.
| Institutions47 holders · as of Mar 31, 2026 · largest filers plus last quarter's tail | ≈ 74.74% | 22.12M shares | |
| Strategic holders1 holder · as of Nov 12, 2025 | 5.49% | 1.62M shares | |
| Otherremainder | ≈ 19.77% | 5.85M shares |
29.59M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
This company has 2 share classes; every stake here is a share of the whole company.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
Barclays PLCStrategic | 5.49% | 1.62M | 13Gfiled Nov 12, 2025 ↗ |
Hudson Bay Capital Management LPInstitution | 5.14% | 1.52M A | 13Fas of Mar 31, 2026 |
Meteora Capital, LLCInstitution | 4.12% | 1.22M A | 13Fas of Mar 31, 2026 |
Glazer Capital, LLCInstitution | 4.04% | 1.20M A | 13Fas of Mar 31, 2026 |
Westchester Capital Management, LLCInstitution | 4.01% | 1.19M A | 13Fas of Mar 31, 2026 |
| See all 25 → | |||
13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more
Insider tradesForm 4
Nothing filed in the last 12 months.
- KKR
Scaled buyout capital for healthcare-services and technology targets.
- Apollo Global Management
Large-scale capital rival for healthcare-services carve-outs and platforms.
- Blackstone
Buyout and growth capital for healthcare software and services assets.
- Intchains Group (ADR)
Cross-border private capital for healthcare-services operators.
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Jackson Acquisition Company II | $10.75 | 0.00% | $318.1M | 36.3 | — | — | — |
| KKR | $107.86 | +1.34% | $95.56B | 33.5 | 15.1 | 4.5 | −44.8% |
| Apollo Global Management | $129.65 | −2.03% | $76.20B | 29.6 | 13.5 | 2.1 | +63.7% |
| Blackstone | $137.00 | +0.12% | $165.28B | 30.4 | 21.3 | 10.3 | +2.4% |
| Intchains Group (ADR) | $0.9400 | −2.68% | $28.4M | — | 6.4 | 3.1 | −72.8% |
| Median | 30.4 | 14.3 | 3.8 | −21.2% |